MAPT and Alzheimer disease: The potential of FMT as a therapy for Alzheimer’s disease is based on the concept that gut microbiota imbalances contribute to neuroinflammation and the progression of amyloid-β and tau pathologies, both of which are central to Alzheimer’s [174].